In Brief This Week: MDxHealth, Agilent Technologies, IsoPlexis, IntegraGen, More
News items for the week of Jan. 9, 2023.
Berkeley Lights Misses 2022 Revenue Estimates
The company blamed delayed Beacon platform placements and lower-than-expected partnership and service contract revenues for the disappointing results.
For proteomics firms, 2022 marked a reversal from an earlier boom, but the field pushed into emerging areas like single-cell, single-molecule, and spatial analyses.
Berkeley Lights Acquiring IsoPlexis in $57.8M All-Stock Deal
IsoPlexis shareholders will receive 0.612 shares of Berkeley Lights stock for each IsoPlexis share with the combined company taking the name PhenomeX.
Earnings Roundup: Prenetics, ProPhase Labs, IsoPlexis, Devyser Diagnostics
Prenetics, ProPhase Labs, IsoPlexis, and Devyser Diagnostics reported their financial results this week.
May 11, 2022
IsoPlexis Q1 Revenues Grow 53 Percent
Mar 2, 2022
IsoPlexis Q4 Revenues Grow 63 Percent
Nov 10, 2021
IsoPlexis Q3 Revenues Grow 28 Percent
Oct 15, 2021
Oct 8, 2021